Story · Health Tech · Medicine & Biotech

STAT+: Doctors have questions about the Watchman. Boston Scientific has a sales pitch.

1 outlet · first reported by STAT Health Tech on

Despite all the setbacks, Boston Scientific won’t stop pushing the Watchman. The medical-device giant committed hundreds of millions to acquire the tiny heart implant more than a decade ago, and then endured a years-long debate at the Food and Drug Administration over whether to approve it. When… (STAT Health Tech)

Coverage, in order

  1. STAT+: Doctors have questions about the Watchman. Boston Scientific has a sales pitch.

    Despite all the setbacks, Boston Scientific won’t stop pushing the Watchman. The medical-device giant committed hundreds of millions to acquire the tiny heart implant more than a decade ago, and then endured a years-long debate at the Food and Drug Administration over whether to approve it. When…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.